Class information for:
Level 1: CANNABINOID//CANNABINOID RECEPTORS//CB2 RECEPTOR

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
241 3838 52.4 86%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
497 3       CANNABINOID//ANANDAMIDE//ENDOCANNABINOIDS 22707
535 2             CANNABINOID//ENDOCANNABINOIDS//ANANDAMIDE 14838
241 1                   CANNABINOID//CANNABINOID RECEPTORS//CB2 RECEPTOR 3838

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 CANNABINOID authKW 2280935 26% 29% 1003
2 CANNABINOID RECEPTORS authKW 1565733 12% 43% 456
3 CB2 RECEPTOR authKW 866060 4% 78% 140
4 CB2 authKW 572273 3% 62% 116
5 ANANDAMIDE authKW 555361 8% 22% 312
6 GPR55 authKW 448438 2% 92% 61
7 ENDOCANNABINOIDS authKW 438494 8% 18% 309
8 CANNABIDIOL authKW 324118 4% 30% 135
9 CB2 AGONIST authKW 221437 1% 80% 35
10 CB1 RECEPTOR authKW 215209 3% 20% 134

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Pharmacology & Pharmacy 16774 39% 0% 1506
2 Neurosciences 4948 23% 0% 867
3 Chemistry, Medicinal 4275 11% 0% 403
4 Biochemistry & Molecular Biology 645 15% 0% 581
5 Medicine, Research & Experimental 492 5% 0% 207
6 Cell Biology 375 7% 0% 274
7 Immunology 350 6% 0% 248
8 Clinical Neurology 157 4% 0% 170
9 Gastroenterology & Hepatology 144 3% 0% 103
10 Anesthesiology 121 1% 0% 54

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ENDOCANNABINOID GRP 198685 3% 23% 110
2 OYO INVEST 134739 1% 71% 24
3 UNIV INVEST NEUROQUIM 97458 1% 51% 24
4 PHYSIOL STUDIES 86340 1% 19% 57
5 SECT OXIDAT ST S TISSUE INJURY 78661 1% 34% 29
6 DR MIRIAM SHELDON G ADELSON BIOL ADDICT DIS 64158 0% 73% 11
7 BIOCHEM MOL BIOL 1 63956 2% 12% 69
8 NEUROSCI DRUG ABUSE PROGRAM 58435 0% 57% 13
9 EUROPEAN BRAIN CERC 58240 1% 26% 28
10 FUNCT SYST NEUROBIOL 50351 0% 33% 19

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BRITISH JOURNAL OF PHARMACOLOGY 32254 7% 2% 269
2 JOURNAL OF NEUROIMMUNE PHARMACOLOGY 18544 1% 6% 38
3 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 5909 3% 1% 127
4 EUROPEAN JOURNAL OF PHARMACOLOGY 5748 4% 1% 145
5 MOLECULAR PHARMACOLOGY 4964 2% 1% 79
6 JOURNAL OF MEDICINAL CHEMISTRY 4237 3% 1% 109
7 LIFE SCIENCES 3337 2% 0% 94
8 VITAMINS AND HORMONES SERIES 3206 0% 7% 6
9 NEUROPHARMACOLOGY 2665 1% 1% 57
10 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY 2218 1% 1% 24

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 CANNABINOID 2280935 26% 29% 1003 Search CANNABINOID Search CANNABINOID
2 CANNABINOID RECEPTORS 1565733 12% 43% 456 Search CANNABINOID+RECEPTORS Search CANNABINOID+RECEPTORS
3 CB2 RECEPTOR 866060 4% 78% 140 Search CB2+RECEPTOR Search CB2+RECEPTOR
4 CB2 572273 3% 62% 116 Search CB2 Search CB2
5 ANANDAMIDE 555361 8% 22% 312 Search ANANDAMIDE Search ANANDAMIDE
6 GPR55 448438 2% 92% 61 Search GPR55 Search GPR55
7 ENDOCANNABINOIDS 438494 8% 18% 309 Search ENDOCANNABINOIDS Search ENDOCANNABINOIDS
8 CANNABIDIOL 324118 4% 30% 135 Search CANNABIDIOL Search CANNABIDIOL
9 CB2 AGONIST 221437 1% 80% 35 Search CB2+AGONIST Search CB2+AGONIST
10 CB1 RECEPTOR 215209 3% 20% 134 Search CB1+RECEPTOR Search CB1+RECEPTOR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 PACHER, P , BATKAI, S , KUNOS, G , (2006) THE ENDOCANNABINOID SYSTEM AS AN EMERGING TARGET OF PHARMACOTHERAPY.PHARMACOLOGICAL REVIEWS. VOL. 58. ISSUE 3. P. 389-462 391 35% 790
2 TABRIZI, MA , BARALDI, PG , BOREA, PA , VARANI, K , (2016) MEDICINAL CHEMISTRY, PHARMACOLOGY, AND POTENTIAL THERAPEUTIC BENEFITS OF CANNABINOID CB2 RECEPTOR AGONISTS.CHEMICAL REVIEWS. VOL. 116. ISSUE 2. P. 519 -560 203 75% 3
3 PACHER, P , MECHOULAM, R , (2011) IS LIPID SIGNALING THROUGH CANNABINOID 2 RECEPTORS PART OF A PROTECTIVE SYSTEM?.PROGRESS IN LIPID RESEARCH. VOL. 50. ISSUE 2. P. 193 -211 185 70% 136
4 LIGRESTI, A , DE PETROCELLIS, L , DI MARZO, V , (2016) FROM PHYTOCANNABINOIDS TO CANNABINOID RECEPTORS AND ENDOCANNABINOIDS: PLEIOTROPIC PHYSIOLOGICAL AND PATHOLOGICAL ROLES THROUGH COMPLEX PHARMACOLOGY.PHYSIOLOGICAL REVIEWS. VOL. 96. ISSUE 4. P. 1593 -1659 365 41% 1
5 TURCOTTE, C , BLANCHET, MR , LAVIOLETTE, M , FLAMAND, N , (2016) THE CB2 RECEPTOR AND ITS ROLE AS A REGULATOR OF INFLAMMATION.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 73. ISSUE 23. P. 4449 -4470 158 80% 3
6 HAN, S , THATTE, J , BUZARD, DJ , JONES, RM , (2013) THERAPEUTIC UTILITY OF CANNABINOID RECEPTOR TYPE 2 (CB2) SELECTIVE AGONISTS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 56. ISSUE 21. P. 8224-8256 180 77% 34
7 HOWLETT, AC , BARTH, F , BONNER, TI , CABRAL, G , CASELLAS, P , DEVANE, WA , FELDER, CC , HERKENHAM, M , MACKIE, K , MARTIN, BR , ET AL (2002) INTERNATIONAL UNION OF PHARMACOLOGY. XXVII. CLASSIFICATION OF CANNABINOID RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 54. ISSUE 2. P. 161 -202 193 49% 1398
8 PACHER, P , KUNOS, G , (2013) MODULATING THE ENDOCANNABINOID SYSTEM IN HUMAN HEALTH AND DISEASE SUCCESSES AND FAILURES.FEBS JOURNAL. VOL. 280. ISSUE 9. P. 1918 -1943 148 57% 104
9 ATWOOD, BK , MACKIE, K , (2010) CB2: A CANNABINOID RECEPTOR WITH AN IDENTITY CRISIS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 160. ISSUE 3. P. 467 -479 112 80% 190
10 CHAKRAVARTI, B , RAVI, J , GANJU, RK , (2014) CANNABINOIDS AS THERAPEUTIC AGENTS IN CANCER: CURRENT STATUS AND FUTURE IMPLICATIONS.ONCOTARGET. VOL. 5. ISSUE 15. P. 5852 -5872 121 72% 24

Classes with closest relation at Level 1


Rank Class id link
1 2851 ANANDAMIDE//FATTY ACID AMIDE HYDROLASE//N ACYLETHANOLAMINE
2 29527 2 ARACHIDONOYLGLYCEROL ANANDAMIDE//ANANDAMIDE TRANSPORT INHIBITORS//ANTIGLAUCOMA ACTIVITY
3 8413 RIMONABANT//ENDOCANNABINOIDS//TARANABANT
4 651 CANNABINOID//CB1 RECEPTOR//ENDOCANNABINOIDS
5 9204 MEDICAL MARIJUANA//CANNABIS//SATIVEX
6 17994 SEZ F BOTTAZZI//SEZ BOTTAZZI//DIPARTIMENTO STUDI
7 22065 MICROSOMAL ALDEHYDE OXYGENASE//XENOBIOT METAB ENVIRONM TOXICOL//7 HYDROXY DELTA8 TETRAHYDROCANNABINOL
8 6717 CANNABIS//MARIJUANA//CANNABIDIOL
9 1728 TRPV1//CAPSAICIN//RESINIFERATOXIN
10 16937 CANNABIS SATIVA//CANNABIS SATIVA L//HEMP

Go to start page